Publications from the Department of Pharmacy Practice faculty at the University of Rhode Island.

Follow

Submissions from 2012

PDF

Fasting Serum C‐Peptide Levels Predict Cardiovascular and Overall Death in Nondiabetic Adults, Nileshkumar Patel, Tracey H. Taveira, Gaurav Choudhary, Hilary Whitlatch, and Wen-Chih Wu

PDF

Curriculum and Instructional Methods for Drug Information, Literature Evaluation, and Biostatistics: Survey of U.S. Pharmacy Schools, Jennifer Phillips, Michael Gabay, Cathy Ficzere, and Kristina E. Ward

PDF

Evaluation of a Program to Improve Diabetes Care Through Intensified Care Management Activities and Diabetes Medication Copayment Reduction, Brian J. Quilliam, Stephen Jon Kogut, Scott Johnson, and Tara Higgins

PDF

Language Impairment in Children Perinatally Infected with HIV Compared to Children Who Were HIV-Exposed and Uninfected, Mabel L. Rice, Ashley L. Buchanan, George K. Siberry, Kathleen M. Malee, Bret Zeldow, Toni Frederick, Murli U. Purswani, Howard J. Hoffman, Patricia A. Sirois, Renee Smith, Peter Torre III, Susannah M. Allison, and Paige L. Williams

Submissions from 2011

PDF

Low Adherence to Outpatient Preoperative Methicillin-Resistant Staphylococcus aureus Decolonization Therapy, Aisling R. Caffrey, Suzanne B. Woodmansee, Nancy Crandall, Cynthia Tibert, Corinne Fielding, Dennis J. Mikolich, Michael P. Vezeridis, and Kerry L. LaPlante

PDF

The Use of Omega-3 Fatty Acids in Mental Illness, Jessica L. Gören and Ashley T. Tewksbury

PDF

Alternatives to potentially inappropriate medications for use in e-prescribing software: triggers and treatment algorithms, Anne L. Hume, Brian J. Quilliam, Roberta Goldman, Charles Eaton, and Kate L. Lapane

PDF

Monitoring and Prevalence Rates of Metabolic Syndrome in Military Veterans with Serious Mental Illness, Sameed Ahmed M. Khatana, Joshua Kane, Tracey H. Taveira, Mark S. Bauer, and Wen-Chih Wu

PDF

Association between Regulator of G Protein Signaling 9–2 and Body Weight, Jeffrey L. Waugh, Jeremy Celver, Meenakshi Sharma, Robert L. Dufresne, Dimitra Terzi, S. Craig Risch, William G. Fairbrother, Rachael L. Neve, John P. Kane, Mary J. Malloy, Clive R. Pullinger, Harvest F. Gu, Christos Tsatsanis, Steven P. Hamilton, Stephen J. Gold, Venetia Zachariou, and Abraham Kovoor

Submissions from 2010

PDF

Prevention of Surgical-Site Infections, Aisling R. Caffrey, Kerry L. LaPlante, and Kalpana Gupta

PDF

Comparative Effectiveness of Linezolid and Vancomycin among a National Cohort of Patients Infected with Methicillin-Resistant Staphylococcus aureus, Aisling R. Caffrey, Brian J. Quilliam, and Kerry L. LaPlante

PDF

Risk Factors Associated with Mupirocin Resistance in Methicillin-Resistant Staphylococcus aureus, Aisling R. Caffrey, Brian J. Quilliam, and Kerry L. LaPlante

PDF

Using Facebook Within a Geriatric Pharmacotherapy Course, Erica L. Estus

PDF

An Active-Learning Course Model to Teach Pharmacotherapy in Geriatrics, Erica L. Estus, Anne L. Hume, and Norma J. Owens

PDF

Development and Delivery of a Quality Improvement Program to Reduce Antipsychotic Polytherapy, Jessica L. Gören, Stuart E. Beck, Barry J. Mills, Derri L. Shtasel, and Robert L. Dufresne

PDF

An Evidence-Based Update On Vitamins, Katherine Kelly Orr and Anne L. Hume

PDF

Cost and Utilization of Behavioral Health Medications Associated with Rescission of an Exemption for Prior Authorization for Severe and Persistent Mental Illness in the Vermont Medicaid Program, Brian J. Quilliam, Jason C. Simeone, and Rita M. Marcoux

Submissions from 2009

PDF

Docetaxel and irinotecan in recurrent or metastatic head and neck cancer, Athanassios Argiris, Ashley L. Buchanan, Bruce Brockstein, Jill Kolesar, Musie Ghebremichael, Michael Pins, Kristine Hahn, Rita Axelrod, and Arlene Forestiere

PDF

Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Lipid-lowering Therapies among Rhode Islanders with Diabetes Enrolled in Medicare Part D Plans in 2006 and 2007, Aisling R. Caffrey, Stephen Jon Kogut, and Lynn Pezzullo

PDF

In Vitro Activities of Telavancin and Vancomycin against Biofilm-Producing Staphylococcus aureus, S. epidermidis, and Enterococcus faecalis Strains, Kerry L. LaPlante and Leonard A. Mermel

PDF

Evaluating Aztreonam and Ceftazidime Pharmacodynamics with Escherichia coli in Combination with Daptomycin, Linezolid, or Vancomycin in an In Vitro Pharmacodynamic Model, Kerry L. LaPlante and George Sakoulas

PDF

Activities of Daptomycin and Vancomycin Alone and in Combination with Rifampin and Gentamicin against Biofilm-Forming Methicillin-Resistant Staphylococcus aureus Isolates in an Experimental Model of Endocarditis, Kerry L. LaPlante and Suzanne Woodmansee

Submissions from 2008

PDF

Methadone Analgesia for Persistent Pain: Safety and Toxicity Considerations, Frederick W. Burgess and Jayne E. Pawasauskas

PDF

Opioid Therapy and Prescription Drug Diversion, Frederick W. Burgess and Jayne E. Pawasauskas

PDF

When Is Antipsychotic Polypharmacy Supported by Research Evidence? Implications for QI, Jessica L. Gören, Joseph J. Parks, Frank A. Ghinassi, Celeste G. Milton, John M. Oldham, Pablo Hernandez, Jeffrey Chan, and Richard C. Hermann

Submissions from 2007

PDF

Integrating Virtual Patients Into a Self-Care Course, Katherine Kelly Orr

Submissions from 2005

PDF

Prescribing of Antipsychotic Medication in a Medicaid Population: Use of Polytherapy and Off-Label Dosages, Robert L. Dufresne, Stephen J. Kogut, and Felix Yam

PDF

Antidespressant-Induced Weight Gain, Sarah Grace Kachur, Christine L. Hannan, and Kristina E. Ward

PDF

Can Robitussin® DM Be Used To Treat Cough During Pregnancy?, Kristina E. Ward

Submissions from 2004

PDF

Multiple Versus Single Antipsychotic Agents for Hospitalized Psychiatric Patients: Case-Control Study of Risks Versus Benefits, Franca Centorrino, Jessica L. Gören, John Hennen, Paola Salvatore, James P. Kelleher, and Ross J. Baldessarini

Submissions from 2002

PDF

Inpatient Antipsychotic Drug Use in 1998, 1993, and 1989, Franca Centorrino, Marion Eakin, Won-Myong Bahk, James P. Kelleher, Jessica L. Gören, Paola Salvatore, Samy Egli, and Ross J. Baldessarini

Submissions from 1996

PDF

Electronic Compliance Assessment of Antifungal Prophylaxis for Human Immunodeficiency Virus-Infected Women, Sandra M. Geletko, Marisel Segarra, Kenneth H. Mayer, Theresa C. Fiore, Frances A. Bettencourt, Timothy P. Flanigan, and Michael N. Dudley

PDF

Clarithromycin Does Not Affect Phosphorylation of Zidovudine In Vitro, Khurram Z. Rana, James W. Darnowski, Andy H. Strayer, and Michael N. Dudley

Submissions from 1995

PDF

Efficacy of Constant Infusion of A-77003, an Inhibitor of the Human Immunodeficiency Virus Type 1 (HIV-1) Protease, in Limiting Acute HIV-1 Infection In Vitro, J. A. Bilello, P. A. Bilello, J. J. Kort, Michael N. Dudley, J. Leonard, and G. L. Drusano

PDF

Population Pharmacokinetics of Stavudine (d4T) in Patients with AIDS or Advanced AIDS-Related Complex, Cynthia M. Horton, Michael N. Dudley, Sanjeev Kaul, Kenneth H. Mayer, Kathleen Squires, Lisa Dunkle, and Robert Anderson

Submissions from 1994

PDF

Effect of 2',3'-Didehydro-3'-Deoxythymidine in an In Vitro Hollow-Fiber Pharmacodynamic Model System Correlates with Results of Dose-Ranging Clinical Studies, John A. Bilello, Gerhard Bauer, Michael N. Dudley, Gerald A. Cole, and George L. Drusano

PDF

Pharmacodynamics of Piperacillin Alone and in Combination with Tazobactam against Piperacillin-Resistant and -Susceptible Organisms in an In Vitro Model of Infection, Andy H. Strayer, Deborah H. Gilbert, Phil Pivarnik, Antone A. Medeiros, Stephen H. Zinner, and Michael N. Dudley

Submissions from 1993

PDF

Dose Ranging and Fractionation of Intravenous Ciprofloxacin against Pseudomonas aeruginosa and Staphylococcus aureus in an In Vitro Model of Infection, C. Randall Marchbanks, Joan R. McKiel, Deborah H. Gilbert, Norman J. Robillard, Barbara Painter, Stephen H. Zinner, and Michael N. Dudley

PDF

In Vitro Postantibiotic Effect Following Repeated Exposure to Imipenem, Temafloxacin, and Tobramycin, Betty J. McGrath, C. Randall Marchbanks, Deborah H. Gilbert, and Michael N. Dudley

Submissions from 1990

PDF

Significance of "Extravascular" Protein Binding for Antimicrobial Pharmacodynamics in an In Vitro Capillary Model of Infection, Michael N. Dudley, Jürg Blaser, Deborah Gilbert, and Stephen H. Zinner

PDF

Pharmacokinetics and Bioavailability of Intravenous-to-Oral Enoxacin in Elderly Patients with Complicated Urinary Tract Infections, C. Randall Marchbanks, Dennis J. Mikolich, Kenneth H. Mayer, Stephen H. Zinner, and Michael N. Dudley

PDF

Pharmacokinetics of Enoxacin and Its Oxometabolite Following Intravenous Administration to Patients with Different Degrees of Renal Impairment, P. Van der Auwera, J. C. Stolear, B. George, and Michael N. Dudley

Submissions from 1988

PDF

Effect of Protein Binding on Drug Penetration into Blister Fluid, Wen Chyi Shyu, Richard Quintiliani, Charles H. Nightingale, and Michael N. Dudley

Submissions from 1987

PDF

Effect of Dose on Serum Pharmacokinetics of Intravenous Ciprofloxacin with Identification and Characterization of Extravascular Compartments Using Noncompartmental and Compartmental Pharmacokinetic Models, Michael N. Dudley, Jon Ericson, and Stephen H. Zinner

Submissions from 1986

PDF

Influence of Medium and Method on the In Vitro Susceptibility of Pseudomonas aeruginosa and Other Bacteria to Ciprofloxacin and Enoxacin, Jürg Blaser, Michael N. Dudley, Deborah Gilbert, and Stephen H. Zinner

PDF

Effect of Saturable Serum Protein Binding on the Pharmacokinetics of Unbound Cefonicid in Humans, Michael N. Dudley, W. C. Shyu, C. H. Nightingale, and R. Quintiliani